Health Care/Hospital

DualityBio's Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designation

SHANGHAI, July 21, 2025 /PRNewswire/ -- DualityBio (HKEX Stock Code: 9606.HK) announced thatthe U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to its next-generation HER3-targeting antibody-drug conjugate (ADC) DB-1310. This designation is for the treatment of ad...

2025-07-22 10:25 2216

Health In Tech Announces Second Quarter 2025 Financial Results

* Revenues of $9.3 million, up 86% YoY; The first-half year revenues of $17.3 million, 89% of full year 2024. * Adjusted EBITDA of $1.6 million, up 134% YoY; The first-half year adjusted EBITDA of$2.8 million, 1.2 times full year 2024. * Cash balance of $8.1 million. STUART, Fla.  , July 21,...

2025-07-22 04:30 2226

2025 Inaugural Global Chest Wall Surgery Conference Concludes Successfully: Uniting Expertise, Driving Innovation

GUANGZHOU, China, July 21, 2025 /PRNewswire/ -- The inaugural Global Chest Wall Surgery Conference concluded successfully inGuangzhou on July 19, uniting leading medical experts worldwide to share cutting-edge surgical innovations and clinical insights inchest wall surgery

2025-07-21 22:33 1855

ICWS Successfully Concludes 2nd Global Program on Cutting-edge Chest Wall Surgery Techniques

GUANGZHOU, China, July 21, 2025 /PRNewswire/ -- The 2nd "Latest Chest Wall Surgery Technique Global Training Program", hosted bythe Institute of Chest Wall Surgery (ICWS) of Guangdong Second Provincial General Hospital, was successfully held fromJuly 16 to 18, 2025. Th...

2025-07-21 22:32 1669

BON Announces $22 Million Distribution Agreement for Weight Loss Products with Beijing Huahai Keyuan Technology Co., Ltd

XI'AN, China, July 21, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural health and personal care industries, today announced it has entered into a non-exclusive sales distribution agreement w...

2025-07-21 21:00 2760

Bloomage Achieves FDA GMP Audit with Zero-Deficiency, Reinforcing Global Trust

PARSIPPANY, N.J., July 21, 2025 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, has announced it successfully passed the U.S. Food and Drug Administration (FDA)'s on-site GMP audit with a "No Action Indicated" (NAI) result. This is the best ...

2025-07-21 21:00 1563

CorestemChemon Expands Global CRO Reach with ATG Lifetech, Targeting Next-Gen Preclinical Services

Strategic partnership to deliver transcriptomics-powered, organoid-based preclinical testing for high-impact drug discovery  SEOUL, South Korea, July 20, 2025 /PRNewswire/ -- CorestemChemon, a leading GLP-certified preclinical CRO based inSouth Korea, has entered into a strategic partnership wit...

2025-07-21 10:54 1567

Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management

BEIJING, July 18, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, a leading global healthcare company, at the 3rd China International Supply Chain Expo in Beijing. Leve...

2025-07-18 20:04 2799

DNAKE Emerges as a Global Innovator in Brain-Computer Interface Technology

XIAMEN, China, July 18, 2025 /PRNewswire/ -- Brain-Computer Interface (BCI) technology is redefining human-machine interaction by establishing direct communication between the brain and external devices. This transformative innovation is driving profound societal impact across industries: revolu...

2025-07-18 16:19 2055

MFDS Clears DeepQure's HyperQure™ for Clinical Trial in Atrial Fibrillation

SEOUL, South Korea, July 17, 2025 /PRNewswire/ -- DeepQure announced today that South Korea's Ministry of Food and Drug Safety (MFDS) has approved a clinical trial of HyperQure™ RDM System, the company's novel laparoscopic renal denervation (RDN) system, for the treatment of atrial fibrillation (...

2025-07-18 10:59 1610

Lifezoom Launches Veyra Series: Flexible Red Light Therapy Panels That Redefine Home Wellness

NEW YORK, July 17, 2025 /PRNewswire/ -- Lifezoom , a pioneer of red light therapy in theUSA, is excited to expand...

2025-07-17 21:03 2693

Co-PSMA trial: Recruitment successfully completed

SYDNEY, July 17, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Co-PSMA (NCT...

2025-07-17 21:01 2019

SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate

* Company aims for technology advancement and platform expansion with Korea's first influenza vaccine using an adjuvant * Interim results from the Phase 1/2 trial expected by 2027, aimed at entering the high-immunogenicity vaccine market * "Our SKYCellflu platform with our adjuvanted vaccine...

2025-07-17 19:00 2024

GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam

YONGIN, South Korea, July 17, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a South Korean pharmaceutical company, announced that its varicella vaccine BARYCELA has received marketing authorization from the Drug Administration of Vietnam (DAV). Following domestic approval in 2020 and WHO Pre-Q...

2025-07-17 13:56 1617

Unlocking New Opportunities in Asia and the Greater Bay Area

SHANGHAI, July 16, 2025 /PRNewswire/ -- CPHI & PMEC China 2025 concluded in June with a record-breaking 109,056 attendees, fostering meaningful connections across the entire pharmaceutical supply chain. This remarkable success is a testament to the strong demand withinChina's thriving pharma indu...

2025-07-17 09:55 1449

Nature Medicine Published Phase 1 Results of Innovent Biologics' Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, July 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...

2025-07-17 08:00 2250

Health In Tech Supports Foster Closet to Help Children and Families in Need

STUART, Fla., July 16, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce its financial support for Community Foster Closet, a local nonprofit in SpokaneValley, Washington, dedicated to providing free clothing...

2025-07-17 04:30 2886

Flat Medical Honored at Premier, Inc.'s Annual Supplier Innovation Celebration

AUSTIN, Texas, July 16, 2025 /PRNewswire/ -- FlatTech LLC, doing business as Flat Medical today announced that it was honored during Premier, Inc.'s annual supplier Innovation Celebration at the 2025Breakthroughs Conference and Exhibition . The Innovation Ce...

2025-07-16 21:30 1726

SNB-101 Earns Government Backing as Promising Therapy for Small Cell Lung Cancer

SEONGNAM, South Korea, July 16, 2025 /PRNewswire/ -- In a strong endorsement of its cutting-edge drug delivery technology, SN BioScience announced that its anticancer candidate SNB-101 has been selected as a clinical-stage project under the 2025 Korea Drug Development Project, a government-initia...

2025-07-16 20:00 1889

The 2025 Mammoth International Contest on Omics Sciences - Young Scientists Track Now Open for Hot Registration!

SHENZHEN, China, July 16, 2025 /PRNewswire/ -- Under the guidance of UNESCO and the United Nations International Cooperation Public Welfare Organization, the 2025 Mammoth International Contest on Omics Sciences - Young Scientist Track (referred to as 2025 MICOS-Youth), co-organized by BGI Researc...

2025-07-16 18:12 1641
1 ... 25262728293031 ... 308